F8 and hemophilia A: Clinical outcome measures for hemophilia A (HA) include several laboratory and clinical evaluations such as factor VIII (FVIII) levels, FVIII inhibitors, overall bleeding rates, joint bleeding rates, target joints, and quality-of-life (QoL) measures [1,2].